GH and IGF-1 work together to provide sermorelin's benefits
Am J Gastroenterol 2018
Using an on-treatment approach, we followed the new users of the drug classes of interest while they remained continuously exposed
However, when significant health problems are driven by weight, we aim for a lower goal and discuss the health problems as well. Options for patients who are not reaching their target At a certain point, patients often reach their personal maximum dose (or dosing maximum) and may still not have lost enough weight to be in a healthier place
Weight loss is a secondary effect
Nevertheless, this meta-analysis found that treatment with semaglutide was associated with increased occurrence of NAION. Broad Trial Review Shows Neutral Retinopathy Risk Following a comprehensive electronic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials, the research team assessed ocular adverse events in 78 randomized clinical trials involving 73,640 adults receiving oral or injectable semaglutide